Year All20242023202220212020201920182017201620152014 Apr 26, 2016 Capnia Commences Serenz® Allergy Relief Product Sales in Europe Apr 20, 2016 Capnia Announces Presentation of CoSense® and Other Pipeline Candidate Data at the 2016 Pediatric Academic Societies Annual Meeting Apr 18, 2016 Capnia Names Rajen Dalal to Board of Directors Mar 24, 2016 Capnia Reports Fourth Quarter and Full Year 2015 Financial Results Mar 16, 2016 Capnia Announces Exclusive Distribution Agreement for Sale of CoSense® in China Mar 14, 2016 Capnia Receives Re-Certification of European CE Mark for Serenz® for the Treatment of Nasal Allergy Symptoms Mar 07, 2016 Capnia Joins the Consortium for Universal Rh Disease Elimination (CURhE) as Founding Member Feb 25, 2016 Capnia Enrolls First Patient in Phase 2 Clinical Trial Evaluating Nasal CO2 for the Symptomatic Treatment of Trigeminal Neuralgia Feb 22, 2016 Capnia’s CoSense® ETCO Monitor to be Showcased at the 2016 Mobile World Congress Feb 16, 2016 Capnia Announces Expiration of Series B Warrants
Apr 20, 2016 Capnia Announces Presentation of CoSense® and Other Pipeline Candidate Data at the 2016 Pediatric Academic Societies Annual Meeting
Mar 14, 2016 Capnia Receives Re-Certification of European CE Mark for Serenz® for the Treatment of Nasal Allergy Symptoms
Mar 07, 2016 Capnia Joins the Consortium for Universal Rh Disease Elimination (CURhE) as Founding Member
Feb 25, 2016 Capnia Enrolls First Patient in Phase 2 Clinical Trial Evaluating Nasal CO2 for the Symptomatic Treatment of Trigeminal Neuralgia